Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB01254 | Dasatinib | 1 | Terminated | 1 |
| DB00619 | Imatinib | 1 | Terminated | 1 |
| DB04868 | Nilotinib | 1 | Terminated | 1 |
| DB08877 | Ruxolitinib | 1 | Terminated | 1 |
| DB06616 | Bosutinib | 1 / 2 | Completed | 1 |
| DB05889 | Inotuzumab ozogamicin | 1 / 2 | Completed | 1 |
| DB01254 | Dasatinib | 2 | Active Not Recruiting | 2 |
| DB08901 | Ponatinib | 2 | Recruiting | 1 |
| DB11581 | Venetoclax | 2 | Active Not Recruiting | 1 |